Evaluation of D-chiro-inositol Treatments
Not Applicable
Completed
- Conditions
- InositolOvulationAsprosinTestosteroneInsulin
- Interventions
- Dietary Supplement: D-chiro-inositol
- Registration Number
- NCT05448378
- Lead Sponsor
- Lo.Li.Pharma s.r.l
- Brief Summary
Healthy women will take tablets containing 600 mg D-chiro-inositol twice per day for one month. We will evaluate metabolic and hormonal.parameters, as insulienmia, glycemia, estradiol, testosterone.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
- Good state of health;
- Regular menstrual cycle.
Exclusion Criteria
- pregnancy;
- delivery in the previous 6 months;
- currently breastfeeding;
- menopause;
- alcohol or drug abuse;
- insulin resistance defined as HOMA-IR index greater than or equal to 2.5;
- other medical morbidities, such as hypertension, PCOS, or diabetes;
- oligomenorrhea or amenorrhea;
- current treatment with corticosteroids or hormones (oral contraceptives, estrogensic, progestogensin);
- use of GnRH analogues, SERMs, or SPRMs within the previous 6 months.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description D-chiro-inositol D-chiro-inositol Patients will take D-chiro-inositol. We will make two blood sampling, at the baseline and after one-month treatment
- Primary Outcome Measures
Name Time Method Testosterone 30 days Serum values of testosterone
- Secondary Outcome Measures
Name Time Method LH 30 days Serum values of LH
DHEAS 30 days Serum values of DHEAS
FSH 30 days Serum values of FSH
Estradiol 30 days Serum values of estradiol
Glycemia 30 days Serum values of glucose
Insulinemia 30 days Serum values of insulin
BMI 30 days body-mass index
HOMA-IR index 30 days Model of assessment for insulin resistance
Asprosin 30 days Serum values of asprosin
Trial Locations
- Locations (2)
ASL Civitavecchia
🇮🇹Roma, Lazio, Italy
ALMA RES
🇮🇹Roma, Lazio, Italy